Tenofovir disoproxil/Emtricitabine 300mg/200mg fixed-dose combination tablets, for oral use clinical trials

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.

This study in France looks at whether a new long-lasting injectable medicine, cabotegravir, can help men who have sex with men (MSM) stick with HIV prevention better than daily pills. It aims to see if it increases how often people use protection and how well it covers risky sexual activities.